Coronary Artery Disease

Orchestra BioMed Starts U.S. Virtue Coronary Balloon Trial as Terumo Reworks Deal With $30M Support

The study pits Virtue against the only FDA-approved coronary drug-coated balloon to generate data for a U.S. submission.